Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06206174
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2024-01-04
Brief Title:
TGRX-814 Chinese Phase III in Patients With Hematological Malignancies
Sponsor:
Shenzhen TargetRx Inc
Organization:
Shenzhen TargetRx Inc
Organization Data
Organization:
Shenzhen TargetRx Inc
Class:
INDUSTRY
Study ID:
TGRX-814-1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shenzhen TargetRx Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Institute of Hematology Blood Diseases Hospital China | OTHER |